Evidence map›Paper›PMID 28440542›Full record

ArticleInternational journal of cancer2017

Menstrual and reproductive factors and lung cancer risk: A pooled analysis from the international lung cancer consortium.

Soumaya Ben Khedher, Monica Neri, Alexandra Papadopoulos, David C Christiani, Nancy Diao, Curtis C Harris, Susan Olivo-Marston, Ann G Schwartz, Michele Cote, Anita Koushik and 12 more

Abstract read
In one paragraph

Article in International journal of cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Body Mass Index (BMI), BMI Change, and Overall Survival in Patients With SCLC and NSCLC: A Pooled Analysis of the International Lung Cancer Consortium.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2019
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Sex-specific Risks in Lung Cancer-Associated Thrombosis: Focus on Female Patients.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Soumaya Ben KhedherUniversité Paris Saclay, Université Paris Sud, UVSQ, CESP, INSERM, Villejuif, France.ORCID 0000-0002-3497-9507
Monica NeriUniversité Paris Saclay, Université Paris Sud, UVSQ, CESP, INSERM, Villejuif, France.
Alexandra PapadopoulosRisk Assessment Department (DER), French Agency for Food, Environmental and Occupational Health Safety (ANSES), Maisons-Alfort, France.
David C ChristianiHarvard TH Chan School of Public Health, Massachusetts General Hospital/Harvard Medical School, Boston, MA.
Nancy DiaoHarvard TH Chan School of Public Health, Massachusetts General Hospital/Harvard Medical School, Boston, MA.
Curtis C HarrisLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Susan Olivo-MarstonLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Ann G SchwartzKarmanos Cancer Institute and Department of Oncology, Wayne State University School of Medicine, Detroit, MI.
Michele CoteKarmanos Cancer Institute and Department of Oncology, Wayne State University School of Medicine, Detroit, MI.
Anita KoushikCRCHUM (Centre de recherche du CHUM) and Department of Social and Preventive Medicine, Université de Montréal, QC, Canada.
Jack SiemiatyckiCRCHUM (Centre de recherche du CHUM) and Department of Social and Preventive Medicine, Université de Montréal, QC, Canada.
Maria Teresa LandiDepartment of Health and Human Services, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Rayjean J HungLunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada.
John McLaughlinLunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada.
Eric J DuellNorris Cotton Cancer Center, Geisel School of Medicine, Dartmouth College Lebanon, NH.ORCID 0000-0001-5256-0163
Angeline S AndrewNorris Cotton Cancer Center, Geisel School of Medicine, Dartmouth College Lebanon, NH.
Irene OrlowEpidemiology and Biostatistics Department, Memorial Sloan Kettering Cancer Center, NY.
Bernard J ParkDepartment of Surgery, Memorial Sloan Kettering Cancer Center, NY.
Hermann BrennerDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Kai-Uwe SaumDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Angela C PesatoriDepartment of Clinical Sciences and Community Health, Università degli Studi di Milano and IRCCS Ca' Granda Foundation, Milan, Italy.
Isabelle StückerUniversité Paris Saclay, Université Paris Sud, UVSQ, CESP, INSERM, Villejuif, France.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Tumor Biology and Microenvironment (Program 1)P30CA022453 · NCI · WAYNE STATE UNIVERSITY · PI Julie Lynn Boerner · 1985 to 2026
$68.4M
Translational Research Support CoreP30ES000002 · NIEHS · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI JAIME ELIZABETH HART · 1985 to 2026
$44.6M
Precision Medicine of CancerZIABC011492 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HARRIS, CURTIS · 2013 to 2025
$23.2M
THE ROLE OF CAL IN CIF-MEDIATED DEGRADATION OF CFTRP20RR018787 · NCRR · DARTMOUTH COLLEGE · PI GERBER, SCOTT · 2003 to 2011
$21.9M
Translational studies of Hsp90 inhibitors in NSCLCP50CA090578 · NCI · DANA-FARBER CANCER INST · PI YEAP, BEOW Y · 2008 to 2012
$11.4M
Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer ResearchR35CA197449 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI XIHONG LIN · 2015 to 2026
$10.9M
Integrative Molecular Epidemiology of Human CancerZIABC011495 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HARRIS, CURTIS · 2013 to 2019
$9.5M
Molecular and Genetic Analysis of Lung Cancer SurvivalR01CA092824 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI CHRISTIANI, DAVID C · 2002 to 2013
$5.9M
SPORE in Lung CancerP20CA090578 · NCI · DANA-FARBER CANCER INSTITUTE · PI JOHNSON, BRUCE E. · 2003 to 2007
$5.1M
GENETIC SUSCEPTIBILITY TO LUNG CANCERR01CA074386 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI CHRISTIANI, DAVID C · 1997 to 2008
$4.8M
Adenocarinoma of the Lung in WomenR01CA087895 · NCI · WAYNE STATE UNIVERSITY · PI SCHWARTZ, ANN G · 2001 to 2005
$3.0M
CCR NIH HHS HHSN261201300011CIntramural NIH HHS Z01 BC005480NCI NIH HHS HHSN261201300011INCI NIH HHS P20 CA090578NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA022453NCI NIH HHS P50 CA090578NCI NIH HHS R01 CA074386NCI NIH HHS R01 CA087895NCI NIH HHS R01 CA092824NCI NIH HHS R35 CA197449NCRR NIH HHS P20 RR018787NIEHS NIH HHS P30 ES000002
6 · The paper itself

Abstract

Many clinical features of lung cancer are different in women and men. Sex steroid hormones exert effects in nonreproductive organs, such as the lungs. The association between menstrual and childbearing factors and the risk of lung cancer among women is still debated. We performed a pooled analysis of eight studies contributing to the International Lung Cancer Consortium (4,386 cases and 4,177 controls). Pooled associations between menstrual or reproductive factors and lung cancer were estimated using multivariable unconditional logistic regression. Subgroup analyses were done for menopause status, smoking habits and histology. We found no strong support for an association of age at menarche and at menopause with lung cancer, but peri/postmenopausal women were at higher risk compared to premenopausal (OR 1.47, 95% CI 1.11-1.93). Premenopausal women showed increased risks associated with parity (OR 1.74, 95% CI 1.03-2.93) and number of children (OR 2.88, 95% CI 1.21-6.93 for more than 3 children; p for trend 0.01) and decreased with breastfeeding (OR 0.54, 95% CI 0.30-0.98). In contrast, peri/postmenopausal subjects had ORs around unity for the same exposures. No major effect modification was exerted by smoking status or cancer histology. Menstrual and reproductive factors may play a role in the genesis of lung cancer, yet the mechanisms are unclear, and smoking remains the most important modifiable risk factor. More investigations in large well-designed studies are needed to confirm these findings and to clarify the underlying mechanisms of gender differences in lung cancer risk.

Indexed as

MenstruationReproductive HistoryAdultAgedAged, 80 and overCase-Control StudiesFemaleHumansLogistic ModelsLung NeoplasmsMenarcheMenopauseMiddle AgedPremenopauseRisk Factorscase-control studieslung neoplasmsmenopausereproductive historywomen

Identifiers

PMID28440542
PMCPMC5642903

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.